About Establishment Labs
Establishment Labs (NASDAQ: ESTA) is a global medical technology company focused on improving patient safety and aesthetic outcomes, initially in the breast aesthetics and reconstruction market by designing, developing, manufacturing and marketing an innovative portfolio of silicone gel-filled breast implants, branded as Motiva Implants®, the centerpiece of the MotivaImagine® platform. In March 2018, Establishment Labs received approval for an investigational device exemption (IDE) from the FDA to initiate the Motiva Implant® clinical trial in the United States. In addition to Motiva Implants®, Establishment Labs’ product and technologies portfolio includes Divina® 3D Simulation System, Puregraft, and MotivaImage® Centers. Additional information about the Company can be found here: http://establishmentlabs.com/.
About Motiva Implants UK
As a recently publicly listed company (NASDAQ:ESTA) and as part of our exciting worldwide growth strategies, we are now able to come to the UK as a direct sales, marketing and supply organisation, with the ability to link British plastic surgeons with our global medical education platform and other value programs. We expect this to have a positive impact on our ability to support you and your patients in this marketplace.
We have local representation, customer care and warehouse teams.
Throughout the years, Motiva Implants® has been established as an innovative product with high levels of security, becoming a well trusted brand among high level plastic surgeons, both in the UK, the EU and globally, thanks to the ongoing Motiva Implants FDA clinical trial program in the United States.
Safety through Innovation is our motto and we live our corporate identity by it every day!